Christopher J Melani, M.D.
National Cancer Institute (NCI)
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Christopher J Melani, M.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:09 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT05371054 · Study of VIP152, Venetoclax, and Prednisone (VVIP) in Relapsed/Refractory Lymphoid MalignanciesNational Cancer Institute (NCI) · completed · Lymphoma, Non-Hodgkin Lymphoma, NHL · principal investigator
- Ph1NCT04739813 · Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid in Combination With Polatuzumab (ViPOR-P) in Relapsed/Refractory B-cell LymphomaNational Cancer Institute (NCI) · active not recruiting · Lymphoma, Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma · principal investigator
- Ph2NCT04002947 · Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell LymphomaNational Cancer Institute (NCI) · recruiting · Non-Hodgkin's Lymphoma, Diffuse Large B-Cell Lymphoma, DLBCL · principal investigator
- Ph2NCT03258567 · Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomasNational Cancer Institute (NCI) · recruiting · Epstein-Barr Virus Infections, Lymphoma, Lymphoproliferative Disorder · principal investigator
- Ph1/Ph2NCT03223610 · Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell LymphomaNational Cancer Institute (NCI) · recruiting · Lymphoma, Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma · principal investigator
- N/ANCT01676805 · Tissue Collection for Studies of Lymph CancerNational Cancer Institute (NCI) · recruiting · Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma · principal investigator
- Ph2NCT00005780 · Chemotherapy Plus Vaccination to Treat Mantle Cell LymphomaNational Cancer Institute (NCI) · completed · Mantle Cell Lymphoma, Lymphoma, Mantle Cell · principal investigator
- Ph2NCT00001379 · Treatment and Natural History Study of Lymphomatoid GranulomatosisNational Cancer Institute (NCI) · completed · Lymphomatoid Granulomatosis, Granulomatosis, Lymphomatoid, Non-Hodgkins Lymphoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:09 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.